Abstract
I am certainly disappointed that Biondi-Zoccai et al. 1 have been disappointed by the recent article, which assessed the risk and cause of death in patients in four pivotal randomized trials of drug-eluting stents (DES) vs. bare metal stents (BMS). The letter raises some interesting issues. Although you state that this was a ‘meta-analysis’, the intent of the manuscript was not to be a meta-analysis. This manuscript included those trials in which the corresponding author (D.R.H.) had access to and was able to review the specific clinical patient notes on each death in these four trials. There was just one data set …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
